Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65.9M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
8.36M
-
Shares change
-
-21.3K
-
Total reported value, excl. options
-
$63.3M
-
Value change
-
-$402K
-
Number of buys
-
32
-
Number of sells
-
-29
-
Price
-
$7.57
Significant Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q1 2019
86 filings reported holding CTSO - Cytosorbents Corp - Common Stock, par value $0.001 per share as of Q1 2019.
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.36M shares
of 65.9M outstanding shares and own 12.69% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.99M shares), VANGUARD GROUP INC (1.37M shares), Skylands Capital, LLC (636K shares), STATE STREET CORP (483K shares), NORTHERN TRUST CORP (349K shares), Allianz Asset Management GmbH (333K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (326K shares), GEODE CAPITAL MANAGEMENT, LLC (322K shares), UNITED SERVICES AUTOMOBILE ASSOCIATION (298K shares), and Sargent Investment Group, LLC (288K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.